Document is current
Any future updates will be listed below
-
Authors
Jiang, Danli
Sun, Wei
Wu, Ting
Zou, Meijuan
Vasamsetti, Sathish Babu
Zhang, Xiaoyu
Zhao, Yihan
Phillippi, Julie A.
Sawalha, Amr H.
Tavakoli, Sina
Dutta, Partha
Florentin, Jonathan
Chan, Stephen Y.
Tollison, Tammy S. https://orcid.org/0000-0002-7193-8456
Di Wu, https://orcid.org/0000-0001-8331-2357
Cui, Jing
Huntress, Ian
Peng, Xinxia
Finkel, Toren https://orcid.org/0000-0002-0726-3546
-
Funding
Funding for this research was provided by:
Pitt | Medical Center, University of Pittsburgh
North Carolina State University
UNC | University of North Carolina at Chapel Hill
Brigham and Women’s Hospital
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG056279, R01AG065229)
- License Information
-
More Information
Article History
Received: 25 January 2021
Accepted: 21 December 2021
First Online: 17 February 2022
Competing interests
: S.Y.C. has served as a consultant for Acceleron Pharma and United Therapeutics; holds research grants from Actelion, Bayer and Pfizer; is a founder, director and officer at Synhale Therapeutics; and holds patents in the therapeutic targeting of metabolism in pulmonary hypertension. All funders had no role in the conceptualization, design, data collection analysis, decision to publish or preparation and revision of the manuscript. The authors otherwise declare no competing interests.
